{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:42:26Z","timestamp":1788792146936,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.psyneuen.2015.09.026","type":"journal-article","created":{"date-parts":[[2015,10,3]],"date-time":"2015-10-03T02:52:02Z","timestamp":1443840722000},"page":"144-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-3791","authenticated-orcid":false,"given":"Brendon","family":"Stubbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre K.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davy","family":"Vancampfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2015.09.026_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psyneuen.2012.06.012","article-title":"The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: olanzapine monotherapy","volume":"38","author":"Ak","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v65n1007","article-title":"Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients","volume":"65","author":"Arranz","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders\u2013DSM-IV-TR","author":"American Psychiatric Association, A.P","year":"2000"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0447.2003.00145.x","article-title":"Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts","volume":"108","author":"Atmaca","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0094112","article-title":"Almost all antipsychotics result in weight gain: a meta-analysis","volume":"9","author":"Bak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/YIC.0b013e3283377850","article-title":"Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis","volume":"25","author":"Basoglu","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0040","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","article-title":"Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome","volume":"37","author":"Beumer","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2008.03.004","article-title":"Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives","volume":"103","author":"Carrizo","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry: Off. J. World Psychiatr. Assoc. (WPA)"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/pcn.12110","article-title":"Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia","volume":"68","author":"Cort\u00e9s","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0060","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.4088\/JCP.13m08820","article-title":"Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients","volume":"75","author":"Ebdrup","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.schres.2004.10.012","article-title":"Letter to the editors: the soluble leptin receptor in olanzapine-induced weight gain: results from a prospective study","volume":"75","author":"Ebenbichler","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ Clin. Res. Ed."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0075","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.pnpbp.2008.03.015","article-title":"Effects of second generation antipsychotics on leptin and ghrelin","volume":"32","author":"Esen-Danaci","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.schres.2007.12.476","article-title":"Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects","volume":"101","author":"Graham","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.npp.1300563","article-title":"Plasma leptin and adiposity during antipsychotic treatment of schizophrenia","volume":"30","author":"Haupt","year":"2005","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2796.2000.00678.x","article-title":"Mechanisms behind gender differences in circulating leptin levels","volume":"247","author":"Hellstr\u00f6m","year":"2000","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/bjp.179.1.59","article-title":"Effects of long-term treatment with antipsychotics on serum leptin levels","volume":"179","author":"Herr\u00e1an","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ Clin. Res. Ed."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2006.08.023","article-title":"Leptin receptor signaling in midbrain dopamine neurons regulates feeding","volume":"51","author":"Hommel","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000122267","article-title":"Increased plasma leptin in sntipsychotic\u2014na\u00efve females with schizophrenia, but not in males","volume":"56","author":"Hsuan Chi","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0115","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v62n1102","article-title":"Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics","volume":"62","author":"H\u00e4gg","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jad.2005.09.015","article-title":"Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia","volume":"90","author":"Jow","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-14-35","article-title":"Visceral obesity in normal-weight patients suffering from chronic schizophrenia","volume":"14","author":"Konarzewska","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmet.2009.06.011","article-title":"Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding","volume":"10","author":"Leinninger","year":"2009","journal-title":"Cell Metabol."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002014","article-title":"Effects of exercise training on cardiorespiratory fitness and biomarkers of cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials","volume":"4","author":"Lin","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pnpbp.2014.12.001","article-title":"Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin","volume":"58","author":"Lu","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/13651501.2010.550400","article-title":"Association of serum levels of leptin, ghrelin, and adiponectin in schizophrenic patients and healthy controls","volume":"15","author":"Tsai","year":"2011","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0155","first-page":"1","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Clin. Trials"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1819.2007.01610.x","article-title":"Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia","volume":"61","author":"Murashita","year":"2007","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0091586","article-title":"Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging\u2014a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts","volume":"9","author":"Neamat- Allah","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.9758\/cpn.2014.12.3.209","article-title":"Regulation of interleukin-6 and leptin in schizophrenia patients: a preliminary analysis","volume":"12","author":"Neelamekam","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.psyneuen.2014.08.017","article-title":"Serum leptin and its relationship with psychopathology in schizophrenia","volume":"50","author":"Nurjono","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000103868","article-title":"Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia","volume":"85","author":"Popovic","year":"2007","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0185","first-page":"S26","article-title":"Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis","volume":"60","author":"Potvin","year":"2015","journal-title":"Can. J. Psychiatry Revnue Can. De Psychiatr."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0007114511005605","article-title":"Impact of age on leptin and adiponectin independent of adiposity","volume":"108","author":"Schautz","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0195","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/schbul\/sbm141","article-title":"Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review","volume":"34","author":"Sentissi","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/acps.12396","article-title":"Difference in inflammatory cytokine production by mononuclear cells from obese and non-obese schizophrenic patients","volume":"132","author":"Sirota","year":"2000","journal-title":"Acta Psychaitr. Scand."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0205","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting meta-analysis of observational studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"August (2)","key":"10.1016\/j.psyneuen.2015.09.026_bib0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/acps.12439","article-title":"The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta\u2010analysis","volume":"132","author":"Stubbs","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0215","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JCP.0b013e3182524393","article-title":"Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia","volume":"32","author":"Sugai","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0220","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1210\/jc.2004-0603","article-title":"Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro","volume":"89","author":"Trujillo","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/08039488.2014.981288","article-title":"Effects of weight loss diet therapy on anthropometric measurements and biochemical variables in schizophrenic patients","volume":"69","author":"Urhan","year":"2015","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0230","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/WNF.0b013e3181fa2a6f","article-title":"A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia","volume":"33","author":"Venkatasubramanian","year":"2010","journal-title":"Clin. Neuropharmacol."},{"issue":"April (4)","key":"10.1016\/j.psyneuen.2015.09.026_bib0235","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review andmeta-analysis","volume":"72","author":"Walker","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0240","unstructured":"Wells, G., B. Shea, D. O'Connell, and J. e. a. Peterson, The Newcastle- Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (last accessed on 29\/09\/2015)."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0245","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.physbeh.2005.06.012","article-title":"Exogenously administered leptin leads to weight loss and increased physical activity in the marsupial Sminthopsis crassicaudata","volume":"85","author":"Wittert","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0250","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/JCP.0b013e318297980e","article-title":"Weight gain in risperidone therapy: Investigation of peripheral hypothalamic neurohormone levels in psychotic patients","volume":"33","author":"Yanik","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0083-6729(05)71012-8","article-title":"Leptin: structure, function and biology","volume":"71","author":"Zhang","year":"2005","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.psyneuen.2015.09.026_bib0260","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1192\/bjp.184.1.58","article-title":"Effects of antipsychotics on fat deposition and changes in leptin and insulin levels: Magnetic resonance imaging study of previously untreated people with schizophrenia","volume":"184","author":"Zhang","year":"2004","journal-title":"Br. J. Psychiatry"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453015009294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453015009294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:51:43Z","timestamp":1759683103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453015009294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":52,"alternative-id":["S0306453015009294"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2015.09.026","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2015.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}